Concepedia

Heather Barnett

HB

Statistics

Publications

9

Citations

474

H-Index

9

Active since

2008

Affiliations

Molecular Discovery (United Kingdom)(Current)

GlaxoSmithKline (Germany)

University of the Arts London

University of Strathclyde

Age UK

Heather Barnett is an author at Molecular Discovery (United Kingdom) specializing in bromodomain inhibition, medicinal chemistry, and pharmacology.

Publications per year

2008–2023

9

Publications

9

GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins

Robert J. Watson, Paul Bamborough, Heather Barnett et al. · Journal of Medicinal Chemistry · 2020 · 87 citations · Full text

, , +9

Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors

Paul Bamborough, Chun‐wa Chung, Rebecca C. Furze et al. · Journal of Medicinal Chemistry · 2015 · 83 citations · Full text

, , +16

Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening

Christopher R. Wellaway, Dominique Amans, Paul Bamborough et al. · Journal of Medicinal Chemistry · 2020 · 71 citations · Full text

, , +14

Defining STEAM Approaches for Higher Education

Claudia Carter, Heather Barnett, Kathryn Burns et al. · European Journal of STEM Education · 2021 · 70 citations · Full text

, , +13

GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain

Paul Bamborough, Heather Barnett, Isabelle Becher et al. · ACS Medicinal Chemistry Letters · 2016 · 66 citations · Full text

, , +14

1–5 of 9